NCT00716040

Brief Summary

All eligible patients will be invited to use electronic monitoring of medication (MEMS) during the next six months. After two months with MEMS the enrolled patients will be randomized to intervention group or to control group. The intervention group will be submitted to four social-psycho sessions with a pre-trained health professional. The control group will receive the usual care of the health service. The study will compare the rate of adherence to antiretroviral therapy between the intervention group and the control group. The duration of the study will be of six months. The analysis will be based on "intention-to-treat.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
121

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2008

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2008

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 16, 2008

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2008

Completed
Last Updated

July 16, 2008

Status Verified

July 1, 2008

Enrollment Period

6 months

First QC Date

July 14, 2008

Last Update Submit

July 15, 2008

Conditions

Keywords

AIDS treatmentHAART adherenceintervention

Outcome Measures

Primary Outcomes (1)

  • Adherence to HAART

    24 weeks

Secondary Outcomes (1)

  • Viral Load

    12 and 24 weeks

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention group will be submitted to four social-psychological individual sessions with a pre-trained health professional.

Behavioral: Social-psycho intervention to improve adherence to HAART

Control

OTHER

The control group will be submitted to the usual care of the health service.

Other: Usual care

Interventions

The intervention focus on the notion of scenes and scenarios to examine and discussing the experience of taking ARV medicines. In principle, such an approach provides a tool for conscientization, action and the invention of novel group and individual repertoires that may result in individual mobilization for improving adherence to treatment and reducing his/her vulnerability.

Intervention

The control group will be submitted to the usual care of the health service

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged more than 18 years old, with detectable viral load and more than six months under HAART

You may not qualify if:

  • Pregnant women
  • Patients participating in other trials
  • Patients in treatment for hepatitis and for active opportunistic infection
  • Patients with mental or physical condition which do not allow their attendance to the health service

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Referência e Treinamento DST/AIDS

São Paulo, São Paulo, 04121-000, Brazil

Location

Related Publications (1)

  • Basso CR, Helena ET, Caraciolo JM, Paiva V, Nemes MI. Exploring ART intake scenes in a human rights-based intervention to improve adherence: a randomized controlled trial. AIDS Behav. 2013 Jan;17(1):181-92. doi: 10.1007/s10461-012-0175-4.

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeHIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Maria Ines B Nemes, PhD

    Faculty of Medicine -University of Sao Paulo

    PRINCIPAL INVESTIGATOR
  • Ernani T Santa Helena, PhD

    Regional University of Blumenau

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 14, 2008

First Posted

July 16, 2008

Study Start

March 1, 2008

Primary Completion

September 1, 2008

Study Completion

November 1, 2008

Last Updated

July 16, 2008

Record last verified: 2008-07

Locations